NCT00191672View on ClinicalTrials.gov

A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

November 30, 2006

Conditions
Breast Neoplasms
Interventions
DRUG

Gemcitabine

DRUG

Paclitaxel

DRUG

Docetaxel

Trial Locations (2)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CT-LILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nashville

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Katy

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00191672 - A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter